BioLine RX Ltd (BLRX) — Net Asset Momentum
BioLine RX Ltd (BLRX) recorded a net asset momentum of 1.8% as of December 2024, with net assets of ILA13.46 Million ILA. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can BioLine RX Ltd fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
BioLine RX Ltd Net Asset Momentum (2005–2024)
This chart tracks BioLine RX Ltd's year-over-year net asset growth across 20 annual reporting periods from 2005 to 2024. The most recent momentum reading is +1.8%, with net assets of ILA13.46 Million ILA as of December 2024. Read BLRX liabilities breakdown for a breakdown of total debt and financial obligations.
Annual Net Asset History for BioLine RX Ltd (2005–2024)
The table below shows the complete annual net asset history for BioLine RX Ltd from 2005 to 2024, covering 20 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see BLRX stock market capitalisation.
| Year | Net Assets (ILA) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | ILA13.46 Million | ILA38.91 Million | ILA25.45 Million | ▲ +1.8% |
| 2023 | ILA13.22 Million | ILA63.92 Million | ILA50.70 Million | ▼ -74.0% |
| 2022 | ILA50.84 Million | ILA76.38 Million | ILA25.54 Million | ▼ -25.3% |
| 2021 | ILA68.09 Million | ILA81.39 Million | ILA13.30 Million | ▲ +209.1% |
| 2020 | ILA22.03 Million | ILA47.29 Million | ILA25.26 Million | ▼ -34.0% |
| 2019 | ILA33.38 Million | ILA53.57 Million | ILA20.19 Million | ▼ -19.2% |
| 2018 | ILA41.32 Million | ILA56.23 Million | ILA14.91 Million | ▼ -21.9% |
| 2017 | ILA52.88 Million | ILA60.97 Million | ILA8.08 Million | ▲ +51.0% |
| 2016 | ILA35.03 Million | ILA38.94 Million | ILA3.91 Million | ▼ -26.4% |
| 2015 | ILA47.61 Million | ILA51.30 Million | ILA3.69 Million | ▲ +49.9% |
| 2014 | ILA31.77 Million | ILA36.17 Million | ILA4.40 Million | ▲ +171.9% |
| 2013 | ILA11.68 Million | ILA19.95 Million | ILA8.27 Million | ▼ -22.0% |
| 2012 | ILA14.97 Million | ILA24.31 Million | ILA9.34 Million | ▼ -33.6% |
| 2011 | ILA22.53 Million | ILA29.34 Million | ILA6.81 Million | ▼ -82.9% |
| 2010 | ILA131.96 Million | ILA154.61 Million | ILA22.65 Million | ▲ +11.9% |
| 2009 | ILA117.94 Million | ILA159.17 Million | ILA41.23 Million | ▲ +50.5% |
| 2008 | ILA78.39 Million | ILA115.73 Million | ILA37.34 Million | ▼ -57.2% |
| 2007 | ILA183.25 Million | ILA207.88 Million | ILA24.63 Million | ▲ +14819.1% |
| 2006 | ILA-1.25 Million | ILA20.12 Million | ILA21.37 Million | ▼ -109.8% |
| 2005 | ILA12.77 Million | ILA20.59 Million | ILA7.83 Million | — |